Summary: <p>Jennifer Quint, Thorax’s Journal Club editor, talks to David Jablons, University of California San Francisco, and consultant for Life Technologies, about his assay to predict survival in resected non-squamous, non-small-cell lung cancer.</p><p>See also:</p><p>http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2811%2961941-7/abstract</p>
